Sisäpiirin ostoja ei ole viime aikoina paljon näkynyt. CEO-Henrik laittanut kuitenkin nyt kättä taskuun.
1 tykkäys
Pieniä on silakat…
Physitrack Agrees Deal to Launch Digital Rehabilitation Across Major UK Healthcare Provider’s National Network
The deal entails enterprise-wide standardisation across 37 clinical sites and approximately 400 practitioner licences nationwide. Approximately £77,000 in annual recurring subscription revenue, representing an initial deployment with expansion potential as the network grows.
LONDON, UK, June 30, 2026
Physitrack plc (Nasdaq First North: PTRK) today announced an agreement generating approximately £77,000 in annual recurring revenue, standardising digital rehabilitation across 37 clinical sites and approximately 400 practitioner licences for one of the UK’s largest independent healthcare providers, with expansion potential as the network grows.
Highlights:
- Approximately £77,000 in annual recurring revenue, with expansion potential
- 37 clinical sites and approximately 400 practitioner licences nationwide
- An existing ecosystem customer now standardising exclusively on Physitrack across its physiotherapy network
- Controlled implementation expected to commence from H2 2026
… mutta laajennusvaraa on kasvun mukana. Ja valuu hyvällä katteella myös alariville. Otetaan toki vastaan hyvät uutiset 
Edit
toinen soppari heti perään
Physitrack Announces Five-Year Enterprise Agreement with Leading UK Private Hospital Network
Under the agreement, the customer will implement Physitrack across its clinical services on an enterprise-wide basis. Five-year contract valued at approximately £255k over the full term.
LONDON, United Kingdom - June 30, 2026
Physitrack plc (Nasdaq First North: PTRK) today announced a five-year enterprise agreement valued at approximately £255k, including approximately £54k of first-year revenue, deploying 400+ licences across a UK private hospital group of more than 30 hospitals.
Highlights:
- Five-year contract valued at approximately £255k; approximately £54k first-year revenue (including a £36k PhysioTools-to-Physitrack upsell)
- 400+ Physitrack licences across 30+ hospitals
- Branded patient applications and EMR/PMS integration
- Phased migration and revenue recognition through 2026
1 tykkäys
Q2 ulkona
- Kohtuulliset kasvuprosentit, absoluuttisesti kuitenkin maltilliset.
- Kassavirta Q2:lla plussalla, mikä on kuluraskaalla kvartterilla hyvä tilanne
- US markkinan RTM -tuote alkanut tuottamaan liikevaihtoa, tähän lienee isoimmat kasvuodotukset
- Omien ostot aloitetaan, niiden käyttötarkoitus kuitenkin vain johdon palkitsemiseen
Aika kädenlämpöinen raportti 
RTM:n osalta raportilta tavoitteita:
Edit:
Redeye oli hieman positiivisemmalla kannalla
2 tykkäystä
US-markkinalla päätä auki, ihan hyvän kokoinen sopimus Physitrackin aiempiin nähden ja osoitus järjestelmän kyvykkyydestä. 
130k$ vuodessa, 3 vuoden sopimus = 390k$
Three-year enterprise agreement with a total contract value of approximately US$390,000 (approximately EUR 336,000) in total, subject to signing of the software services agreement.
New York City, September 7, 2026
Physitrack PLC (Nasdaq First North Premier Growth Market: PTRK), a global provider of digital health and wellbeing technology, today announces that it has been selected as the preferred digital rehabilitation technology by a large US academic healthcare system following a competitive selection process.
The customer has confirmed that Physitrack’s commercial proposal, of approximately US$390,000 in total, is in line with its expectations. The parties have now entered the software services agreement review and contracting phase.
The proposed commercial terms cover a three-year relationship with a break option after the second year. This would represent approximately US$260,000 (approximately EUR 224,000) in committed revenue across the first two years and a potential total contract value of approximately US$390,000 over the full three-year period.
Tulee toki näkymään liikevaihdossa vasta vuoden päästä, että asiakkaan integroinnit saadaan valmiiksi
Implementation will follow the customer’s clinical systems integration timetable, with go-live expected in late 2027. Revenue will be recognised from go-live and phased across the contract term, commencing in the financial year ending 31 December 2027.
2 tykkäystä
Toinen US-diili perään. Alkaa vaikuttaa huomattavasti paremmalta
Physitrack Selected by US Metropolitan Healthcare System for Enterprise-Wide, Epic-Integrated Digital Rehabilitation
Three-year enterprise agreement with a total three year contract value of approximately US$78,000 (approximately EUR 67,000) in total, covering an enterprise-wide deployment and full Epic and MyChart integration.
Physitrack PLC (Nasdaq First North Premier Growth Market: PTRK), a global provider of digital health and wellbeing technology, today announces that it has been selected as the digital rehabilitation platform for a US metropolitan safety net healthcare system, following a competitive selection process.
The agreement covers a three-year relationship with a break option after the second year. It represents annual recurring revenue of approximately US$26,500 (approximately EUR 22,800) in the first year, rising by a fixed 5% on each anniversary. This equates to approximately US$54,000 (approximately EUR 47,000) in committed revenue across the first two years and a potential total contract value of approximately US$83,000 over the full three-year period. Remote therapeutic monitoring usage is billed in addition to these figures, on actual usage.
The selection displaces two incumbent home exercise programs vendors and consolidates the customer’s physical therapy, occupational therapy and speech therapy services onto a single standardized platform, covering 86 licensed practitioners. It further strengthens Physitrack’s position within the US enterprise healthcare market and within the public and non-profit provider segment.
Lisäksi tekeillä jotain uutta, linkkaripostauksia ollut muutaman viikon ajan, viimeisin
Aiemmassa postauksessa Molinin kommentti
Eli oletettavasti EMR ja tässä yhteydessä olettaisi olevan AI-avusteinen potilastietojärjestelmä 
1 tykkäys
Tämän nyt ei enää pitäisi tulla yllätyksenä, eli EMR julkaistu.
Physitrack Launches Next-Generation EMR, Powered by Agentic AI
Physitrack plc (Nasdaq First North: PTRK) launches AI agentic EMR that turns the consultation itself into the clinical record, moving the company from a tool inside the clinician’s stack to the system of record the stack runs on.
NEW YORK, United States — 28 September 2026
Physitrack plc (Nasdaq First North: PTRK) d/b/a Physitrack Group, a global provider of AI-powered software for healthcare and workplace wellbeing, today announced the launch of its own electronic medical record (EMR) for physical therapy and rehabilitation practices in the United States.
The launch represents a strategic expansion of Physitrack’s existing offering. Historically, Physitrack has operated alongside third-party electronic medical records, providing patient engagement, exercise prescription, outcomes tracking and remote care capabilities. With its own EMR, Physitrack can now become the system in which the clinical workflow itself is managed.
Built around an agentic AI architecture that leverages off Physitrack’s unique database of 10 years of clinical data, the EMR is designed to reduce the administrative burden associated with running a rehabilitation practice. During a patient consultation, the system can draft clinical notes from the conversation, suggest an appropriate exercise program for clinician review and, following approval, deliver the programme directly to the patient through PhysiApp.Strategic rationale
Electronic medical records sit at the center of a healthcare practice, connecting patients, clinicians, appointments, documentation and, increasingly, payments and reimbursement.Physitrack believes that expanding into this system-of-record layer creates an opportunity to increase the breadth of its relationship with customers, expand subscription revenue per provider over time and further integrate its existing products into customers’ daily workflows.
Ei tämä nyt helppo ja nopea laajentumismahdollisuus ole. Kohdemarkkina on kuitenkin pienemmät klinikat, joissa kynnys järjestelmän vaihtoon on pienempi.
The initial target market is solo and small physiotherapy and rehabilitation practices in the United States.
The company has also developed an integration with Claim.MD, a US healthcare claims clearinghouse, as part of its billing and insurance claims workflows.This is intended to extend the same approach to administrative processes following a consultation, creating a more integrated workflow from patient appointment through clinical documentation, treatment and reimbursement.
Jonon kautta sisään testijaksolle. Laskutus alkaa rullaamaan sitten tammikuussa
Commercial rollout
Early access opens on 28 September 2026 for practices in the United States.
Access will initially be managed through a waitlist, allowing Physitrack to scale onboarding, product development and customer support alongside adoption.
The product will remain free throughout the early access period. Paid subscriptions are planned from January 2027.
The company will evaluate adoption, customer feedback and usage during the early access period before providing further information regarding the commercial development of the product.
Mielenkiintoinen tuo kommentti, että klinikat vaihtaisivat käytettäviä järjestelmiä usein. Kuulostaa omaan arvioon hieman erikoiselta väitteeltä, mutta ehkä sitten niin
Why this matters commercially
An electronic medical record is where a practice keeps its patients, its notes and its schedule. Clinics change the tools around the record often, and change the record itself rarely. Moving from a product used alongside the practice’s system to the system itself increases what Physitrack is worth to each customer, and how long those customers stay.The global Physical Therapy EMR TAM is around $1.43 billion to $1.60 billion today. The broader market is projected to scale up to $2.5 billion – $3.4 billion by 2030–2035.
This launch thus represents a significant shift in Physitrack’s total addressable market for its Lifecare segment, and carries substantial potential upside for revenue generation.
Comment from CEO Henrik Molin
“Launching our own EMR is an important strategic step for Physitrack,” said Henrik Molin, CEO and Founder of Physitrack PLC.“For more than a decade, we have built technology that clinicians use alongside their clinical systems. We now have the opportunity to bring those capabilities together within the system at the centre of the practice itself.
“Our objective is straightforward: reduce the amount of time clinicians spend on administration and allow them to spend more time treating patients. The consultation can become the clinical record, the record can inform the treatment programme, and the clinician remains in control throughout. Billing and insurance claims workflows ensure that the clinic seamlessly gets paid for their services.
“From a commercial perspective, becoming part of the core clinical workflow also gives us the opportunity to deepen our relationship with customers and expand the value of the Physitrack platform over time. We are approaching that opportunity in a disciplined way, beginning with free early access in the United States before introducing paid subscriptions in 2027.”
Redeylle laajennus maistuu ja lähestymistapa kaupallistamiseen on järkevä
Physitrack has launched its own electronic medical record (EMR [sv. elektronisk patientjournal]) for US physical therapy clinics — an AI tool that writes the clinical notes during the consultation and turns them straight into a treatment plan. Until now Physitrack sold add-on software that clinics used next to their EMR. Now Physitrack can be the EMR itself, and that’s a bigger prize: it opens a $1.4–1.6bn market (growing to $2.5–3.4bn) versus the narrower add-on niche Physitrack served before. Redeye’s take: this is a clearly positive strategic move — it deepens the moat and raises the revenue ceiling per clinic, with no 2026 revenue impact since paid subscriptions only start January 2027. We leave our valuation unchanged for now, but see this as a genuine upside lever for 2027 and beyond, and we like the direction management is taking the business.
3 tykkäystä
Varsin hyvä startti testijaksolle 
https://x.com/physitrack/status/2106401806850883876
Jatketaan tähän samaan vielä päivän tiedote kaupallisesta mallista ja alustavista hinnoista
Physitrack sets out commercial model for its EMR as more than 100 clinics sign up for early access in five days
Physitrack announces the commercial model for its next-generation EMR following more than 100 clinics, representing over 500 potential end users, signing up for early access in the first five days.
NEW YORK, United States — October 5 2026
Physitrack Plc (Nasdaq First North Premier Growth Market: PTRK), a global provider of AI-powered clinical software for rehabilitation and workforce wellbeing, today announced further details of the commercial model for Physitrack EMR, its recently launched next-generation electronic medical record for physical therapy and rehabilitation practices.
The launch has generated strong initial demand, with more than 100 clinics representing well over 500 potential end users signing up for early access to Physitrack EMR in the first five days following its launch on 28 September 2026.
Commercial model
The EMR is sold as a single bundle with Physitrack’s existing home exercise prescription (HEP) subscription and Remote Therapeutic Monitoring (RTM), with optional add-ons available on top. In the US:
- Early access is free until 1 January 2027.
- Clinics that join before then pay a founder rate of $41.99 per user per month for 12 months.
- The list price from 1 January 2027 is $59.99 per user per month.
- The optional AI scribe add-on costs $19 per clinician per month ($15 at the founder rate), for a full list price of $78.99.
- RTM patient usage is priced separately at $8 per active plan of care.
The Group also expects to introduce payment processing functionality within Physitrack EMR during 2027, enabling clinics to collect patient payments directly through the platform.
1 tykkäys
Jatketaan nyt vielä, kasvaa sen verran hyvin tuo testijaksolle kirjautuneiden määrä 
1000 klinikkaa 9:ssä päivässä - kysyntää ja kiinnostusta on
Tuolta lisää EMR:stä. Näyttää kyllä päälle päin varsin pätevältä apurilta 
Korjauksena yllä olevaan: kliinikkoa, ei klinikkaa
Tahti kuitenkin jatkuu hyvänä
Physitrack PLC (Nasdaq First North Premier Growth Market: PTRK) today announces that since its introduction on 28 September, its next-generation EMR has attracted registrations from more than 300 clinics representing over 2,100 practitioners. The number of practitioners represented on the waitlist has doubled in just five business days, indicating an acceleration in the pace of registrations.
Edit: päivitys 19.10.
Physitrack EMR early access reaches 480 clinic signups representing over 4,700 clinicians
Physitrack’s new EMR has attracted signups from 480 clinics representing over 4,700 clinicians ahead of its wider launch on 2 November 2026. A Physi Campus development sprint beginning on 13 November will accelerate revenue cycle management and reporting capabilities, targeted for release in early December. Paid subscriptions remain on track to commence in January 2027.
New York, October 17, 2026
Physitrack PLC announces that 480 clinics, representing over 4,800 clinicians, have signed up for its new Physitrack EMR ahead of the wider launch scheduled for 2 November 2026.
The signup figures demonstrate strong early interest in Physitrack’s AI-powered electronic medical record platform, designed to simplify clinic workflows, reduce administration and connect clinical care with patient engagement.
1 tykkäys
Q3 tuli tässä viikolla, työkiireiden takia vähän viiveellä omat kommentit, kun ei muita aktiivisia kirjoittajia näköjään löydy 
Hyvää kasvua ja valuu nyt myös alariville asti kun kertakulut on käsitelty ja heikomman katteen toiminnot siirretty eteenpäin.
Physitrack Plc: Interim Report Q3 2026 – Growth Accelerating: Revenue Up 14 per cent, Two US Healthcare System Selections, EMR Launched, Company Profitable and Cash Generative
Third quarter: 1 July – 30 September 2026
Based on Alternative Key Performance Measures, the Company’s key financial highlights for the period are summarised below.
- Revenue increased 14 per cent to EUR 3.6m (EUR 3.2m), or 11 per cent at constant currency, the strongest growth of the year.
- Subscription revenue continued to represent the majority of Group revenue (94 per cent), reflecting the strength of the recurring SaaS model.
- Adjusted EBITDA decreased 8 per cent to EUR 1.1m (EUR 1.2m), corresponding to a margin of 31 per cent (38 per cent), reflecting deliberate investment in the North American commercial team and product launch activity.
- Adjusted EBITDA less CapEx decreased to EUR 0.3m (EUR 0.4m), with Group CapEx held at EUR 0.8m, in line with recent quarterly run rates, despite three product launches in the quarter.
- Operating cash flow from continuing operations amounted to EUR 1.1m (EUR 1.3m), with operating cash flow before adjusting items representing 106 per cent of adjusted EBITDA, marking the eighth consecutive quarter of positive operating cash flow.
- Free cash flow from continuing operations was positive at EUR 0.2m (EUR 0.5m). Net debt reduced to EUR 3.7m (30 June 2026: EUR 3.9m) and available liquidity was EUR 1.9m.
Jatkon osalta US-markkinan avaukset määrittää suunnan. Potentiaalia on tuplata liikevaihto EMR:n ja sen lisäpalveluiden kautta, varsinkin kun julkaistaan myös Australia, UK jne markkinoille.
Kannattavuus olisi sen jälkeen ihan eri luokkaa ja sitä kautta myös arvostus pitäisi aika pian ottaa loikkaa eteenpäin.
Redeyn kommentit ja Molinin haastattelu
https://www.redeye.se/research/1188215/physitrack-q3-interview-the-emr-has-become-a-global-play
3 tykkäystä
Tämä ei olekaan ihan pieni markkina 
toiselta foorumilta lainattuna ilman mitään vastuuta tai tarkistusta
Indien - Ca 50 000 - 150 000 aktiva fysios i
UK - 36 000 - 58 000
USA - 230 00 - 250 000
Sverige - 12 000 - 16 000
2 tykkäystä
EMR:stä ja kokonaisuudesta alkaa tulla todella iso potentiaali kasvulle. Julkaisu menossa nyt kaikkiin englanninkielisiin toimintamaihin.
700 klinikkaa ja lähes 7000 tekijää nyt kokeilujaksolla. Lisää tulee vielä parin kuukauden ajan. Konversio näistä maksaviksi asiakkaiksi vuodenvaihteessa on sitten se mielenkiintoinen vaihe. Ainakin G2 rating lupaa hyvää tältä osin.
Koko pressi tuohon alle, niin saa lukea ihan itse, jos kiinnostaa 
Physitrack Releases its Agentic AI EMR to Clinics Worldwide, Rated #3 EMR by G2
Physitrack plc (Nasdaq First North: PTRK) opens general access to its AI agentic EMR, moving from a managed United States waitlist to open availability in English across all markets.,Physitrack EMR ranked third among EMR software for physical therapy on G2, the independent software review platform.
NEW YORK, United States, November 2, 2026
Physitrack plc (Nasdaq First North: PTRK), a global provider of AI-powered software for healthcare and workplace wellbeing, today announced that its Electronic Medical Record (’EMR’) is available to physical therapy and rehabilitation practices in every market in which the company operates, in English, without a waitlist.
From waitlist to free trial
The EMR launched on September 28, 2026 for practices in the United States, with access managed through a waitlist. That early access period has now concluded with over 800 clinics signing up, representing 5,600 end users, which if all converted to paid subscriptions would represent €2.6m-4m in ARR from 2027 at current pricing of the early access monthly rate at $39.99 and the AI Scribe at $19. From today, any practice can register directly and begin a free trial, with no waitlist and no delayed onboarding.The product remains free to use. Paid subscriptions are planned from January 2027. The EMR is sold on its own, with Physitrack’s home exercise prescription platform available as an optional add-on.
The EMR supports patient self-pay billing from today. Revenue cycle management and insurance claims workflows, including the previously announced Claim.MD integration, are planned from January 2027 for the United States, Australia, the United Kingdom and Canada.
Responding to high demand across the globe
Demand ran well beyond the market the early access period was designed for. The waitlist drew over 800 clinic registrations from 60 countries, without paid promotion.The global Physical Therapy EMR TAM is around $1.43 billion to $1.60 billion today, projected to scale to $2.5 billion to $3.4 billion by 2030 to 2035. English-speaking markets account for approximately two thirds of that total, or around $0.95 billion to $1.10 billion today. From today the Physitrack EMR is available across all of them to use for free until January 2027, at which point charging commences.
Ranked third physical therapy EMR on G2
Five weeks after the early release launch, Physitrack EMR is ranked third among EMR software for physical therapy on G2, the independent software review platform. G2 rankings are based on verified user reviews and G2 does not accept paid placements. The ranking places a product that has been live for five weeks alongside systems that have served physical therapy practices for many years.From a standalone HEP company, to an EMR company - and the commercial opportunities that presents
Physitrack is becoming an EMR company - this matters commercially as clinicians initially buy an EMR when setting up their practice and then add on other software. Meaning Physitrack becomes the spine of the clinic’s software stack.Practices that sign up before 1 January 2027 keep a founder rate of $39.99 per user per month for 12 months from the day charging begins. For practices signing up from 1 January 2027, the EMR costs $59.99 per user per month. In addition, users can choose to add Physitrack’s Home Exercise Prescription platform (’HEP’) for $23.99 per user per month and an AI scribe for $19 per user per month. Additional costs for Remote Therapeutic Monitoring (USA-only), Telehealth and billing will also be charged for.
Comment from CEO Henrik Molin
“We said in September that we would launch properly, listen to the practices using it and then scale,” said Henrik Molin, CEO and Founder of Physitrack PLC.“The product has been in the hands of clinicians for five weeks, activation and usage has exceeded 70% of early access users, we have learned a great deal from them, and we are now confident enough to open it to everyone.”
“We are pleased to see significant interest from across the globe and I can confirm the EMR will be available for English language users wherever they are based.”
"Our discipline on the commercial side has not changed. The product has now moved from waitlist to being open to use by anyone, with charging beginning in the new year. What changes today is the size of the opportunity in front of us. It’s multiplied since we first launched for just US users.”
“On the back of this initial success, we are also exploring adapting the EMR to multiple additional manual care specialists, including Chiropractors and Osteopaths. Down the line, we are open to launching access to mental health and general healthcare segments as we keep evolving this very exciting new business line.”
Lisäksi vielä Molinin haastattelua EMR:stä
https://www.mobihealthnews.com/news/qa-physitrack-launches-agentic-ai-emr-physical-therapy-practices
3 tykkäystä